Effect of azoles on the secretion of a Candida albicans metallopeptidase. 2006

Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
Unité de recherche en biologie parasitaire et fongique, Laboratoire de parasitologie et mycologie médicales, CHU La Milètrie, Poitiers, France. parasitologie@univ-poitiers.fr

Azole antifungals act by inhibiting the activity of a lanosterol demethylase involved in the generation of the ergosterol of the cellular membrane of fungi. These drugs could also have action on other yeast components, like secreted aspartyl proteases. We demonstrate in this study that the in vitro secretion of a metallopeptidase could be modified during the growth of Candida albicans with subinhibitory concentrations of some azoles. Eight isolates of this yeast have been cultivated in presence of MIC, MIC/2 and MIC/4 of voriconazole, fluconazole and itraconazole. The presence of voriconazole and fluconazole decreased the secretion of the metallopeptidase in the culture medium, whereas itraconazole increased this secretion for three isolates. This study points to the fact that some antifungals, given in prophylaxis, could act in an unfavourable way on some potential factors of pathogenicity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D045726 Metalloproteases Proteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS. Metallopeptidase,Metalloprotease,Metalloproteinase,Metalloproteinases,Metallopeptidases

Related Publications

Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
October 1995, Journal of medical microbiology,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
August 1999, FEMS microbiology letters,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
June 2016, Indian journal of microbiology,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
January 2019, Revista iberoamericana de micologia,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
January 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
January 2018, International journal of antimicrobial agents,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
January 2020, Frontiers in microbiology,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
June 2021, Letters in applied microbiology,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
December 1997, Revista iberoamericana de micologia,
Christine Imbert, and Sabrina Imbert-Bouyer, and Catherine Kauffmann-Lacroix, and Gyslaine Daniault, and Marie-Hélène Rodier
January 2010, Journal of applied microbiology,
Copied contents to your clipboard!